Sample | Title | Value | Rank |
GSM451635 | M15 - infected MBT/Pas fibroblasts (9 h post inf) | 1423.5 | 96 |
GSM451636 | M16 - infected MBT/Pas fibroblasts (9 h post inf) | 1877.5 | 97 |
GSM451637 | M17 - infected MBT/Pas fibroblasts (9 h post inf) | 1412.8 | 96 |
GSM451632 | M11 - non-infected MBT/Pas fibroblasts | 1165.7 | 96 |
GSM451633 | M12 - non-infected MBT/Pas fibroblasts | 1267.9 | 96 |
GSM451634 | M13 - non-infected MBT/Pas fibroblasts | 1508.7 | 97 |
GSM451629 | B15 - infected BALB/cByJ fibroblasts (9 h post inf) | 2019 | 98 |
GSM451630 | B16 - infected BALB/cByJ fibroblasts (9 h post inf) | 1383.6 | 96 |
GSM451631 | B17 - infected BALB/cByJ fibroblasts (9 h post inf) | 1547 | 97 |
GSM451626 | B11 - non-infected BALB/cByJ fibroblasts | 1821 | 97 |
GSM451627 | B12 - non-infected BALB/cByJ fibroblasts | 1445.2 | 97 |
GSM451628 | B13 - non-infected BALB/cByJ fibroblasts | 1749.3 | 97 |